Breaking News

You are here » Indian-Commodity  :  Commodities  :  Copper  :  Copper futures trade lower on MCX

10-Aug2018

Copper futures trade lower on MCX

Copper futures traded lower on MCX, due to fresh selling by market players in line with the news that United States geared up to begin collecting tariffs on a further $16 billion of Chinese goods later this month. Even though, a weaker dollar trimmed the downward momentum.

The contract for August delivery was trading at Rs 418.90, down 0.53% or Rs 2.25 from its previous closing of Rs 421.15. The open interest of the contract stood at 28324 lots.

The contract for November delivery was trading at Rs 426.10, down by 0.53% or Rs 2.25 from its previous closing of Rs 428.35. The open interest of the contract stood at 828 lots on MCX.


Related News

View all news

Copper futures end lower on Thursday

Copper futures ended lower on Thursday, following Chinese stock markets lower on the prospect of slowing global economic growth. Further, concerns over US interest rates and the US-China trade war too......

Copper futures end lower on Thursday

Copper futures ended lower on Thursday, following Chinese stock markets lower on the prospect of slowing global economic growth. Further, concerns over US interest rates and the US-China trade war too......

Copper futures end tad lower on trade war concerns

Copper futures ended marginally lower on Monday on account of lingering trade war concerns between the United States and the world's top industrial metals consumer China.Copper futures for December delivery......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......